CVC, Charterhouse and Avista Capital Partners together with the founder of Vemedia Pharma acquiren Cooper

 

 

 


/COMUNICAE/

Cooper Consumer Health, a leading laboratory for the manufacture and marketing of pharmaceutical products, has announced the appointment of Bart Meermans as the new CEO of the International Group. In addition, Cooper Consumer Health has reached an agreement to buy Lashilé Beauty, a French consumer health food supplement company

To carry out the acquisition of Cooper Consumer Health, CVC partnered with the founder of Vemedia, Yvan Vindevogel, the specialized medical care fund Avista Capital Partners and Charterhouse, which made a significant reinvestment in the company.

 

Cooper Consumer Health has also just purchased the French Nutraceutical firm Lashilé Beauty, a leader of the French market in the growing category of food supplements. The business fits perfectly with the company's comprehensive strategy, thanks to a portfolio of complementary products with attractive underlying growth, a scalable business model that can be implemented internationally and a strong digital and online marketing knowledge.

The founders of Lashilé Beauty will also become shareholders of Cooper Consumer Health. The entry into exclusive negotiations was initially announced earlier this year and the new shareholders are excited to support the company's organic and purchasing growth plans.

Bart Meermans, new CEO of Cooper
The new CEO of Cooper Consumer Health, Bart Meermans is happy to join the team and accompany the company on the journey that will make the company leader of the European health sector. He believes that providing personal care to people to better care for their health is significant and inspiring, and also opens an important pathway for growth. Guias y Trucos tecnologicos

Vemedia, reference in self-care
Vemedia Pharma, established on Iberia of the Cooper Consumer Health Group, specializing in the sale of products for the self-care of health, based in Barcelona, has 60 employees in Spain.

 

The firm has a wide range of products such as Valdispert®, Meladispert®, Oenobiol®, Excilor®, Zeninas®, Audispray® and Roter®.

About Cooper Consumer Health
Cooper Consumer Health is a leading pan-European self-care platform, with net sales totalling 500 million euros. The group has a direct presence in six European markets and is exported to more than 30 countries where it sells a large portfolio and employs 850 workers.

About CVC
CVC is a leading investment and private capital consulting firm with a network of 25 offices in Europe, Asia and the United States, with approximately $125 billion in assets under administration. Since its founding in 1981, CVC has secured debt commitments for more than $165 billion from some of the world's leading institutional investors in its private capital and credit strategies. Funds managed or advised by CVC are invested in more than 100 companies worldwide, who have combined annual sales of more than $10 billion and employ more than 450,000 people.

CVC, Charterhouse and Avista Capital Partners together with the founder of Vemedia Pharma acquiren Cooper

CVC, Charterhouse and Avista Capital Partners together with the founder of Vemedia Pharma acquiren Cooper

Cooper Consumer Health, a leading laboratory for the manufacture and marketing of pharmaceutical products, has announced the appointment of Bart Meermans as th

nails

en

https://doityour.health/static/images/nails-cvc-936-0.jpg

2024-05-20

 

CVC, Charterhouse and Avista Capital Partners together with the founder of Vemedia Pharma acquiren Cooper
CVC, Charterhouse and Avista Capital Partners together with the founder of Vemedia Pharma acquiren Cooper

Acording with the Digital Millennium Copyright Act (“DMCA”), Pub. L. 105-304 If you believe that your copyrighted work is being infringed, notify our team at the email [email protected]